Latest news
UMass Chan licenses potential small molecule immunotherapeutic for cancer treatment to ImmVue Therapeutics Inc.
Toronto-based ImmVue Therapeutics Inc. has exclusively licensed allosteric small molecule compounds identified in the laboratory of Joonsoo Kang, PhD, professor of pathology at UMass Chan Medical School, for clinical development as a potential cancer therapeutic.
Read more